Abe Shuhei, Miura Kiyonori, Kinoshita Akira, Mishima Hiroyuki, Miura Shoko, Yamasaki Kentaro, Hasegawa Yuri, Higashijima Ai, Jo Ozora, Yoshida Atsushi, Kaneuchi Masanori, Yoshiura Koh-Ichiro, Masuzaki Hideaki
Department of Obstetrics and Gynecology, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Department of Human Genetics, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
J Hum Genet. 2014 May;59(5):251-5. doi: 10.1038/jhg.2014.9. Epub 2014 Feb 13.
The relationship between oncogenic human papillomavirus (HPV) infection and later cytological findings in the uterine cervix is unknown in women who were negative for intraepithelial lesion and malignancy (NILM) or atypical squamous cells of undetermined significance (ASC-US). This was investigated in this study in a Japanese population to determine the clinical utility of oncogenic (HPV) genotyping. The relative risk of progressive cytological findings 2 years after identification of oncogenic HPV infection was higher than in cases of non-oncogenic HPV infection (relative risk 3.827; 95% confidence interval (CI): 1.282-11.422), as well as in cases of negative HPV infection (relative risk 2.124; 95% CI: 1.451-3.110). Moreover, the relative risk of progression of cytological findings 2 years later in cases of HPV-16 infection was higher than in cases of HPV-52 infection (relative risk 2.094; 95% CI: 1.005-3.935). Therefore, the initial HPV-DNA genotype may be a potential predictive marker of later progression of cytological findings in the uterine cervix in cases of NILM or ASC-US.
对于上皮内病变和恶性肿瘤呈阴性(NILM)或意义不明确的非典型鳞状细胞(ASC-US)的女性,致癌性人乳头瘤病毒(HPV)感染与随后子宫颈细胞学检查结果之间的关系尚不清楚。本研究在日本人群中对此进行了调查,以确定致癌性(HPV)基因分型的临床效用。致癌性HPV感染确诊2年后出现细胞学检查结果进展的相对风险高于非致癌性HPV感染病例(相对风险3.827;95%置信区间(CI):1.282 - 11.422),也高于HPV感染阴性病例(相对风险2.124;95% CI:1.451 - 3.110)。此外,HPV - 16感染病例2年后细胞学检查结果进展的相对风险高于HPV - 52感染病例(相对风险2.094;95% CI:1.005 - 3.935)。因此,对于NILM或ASC-US病例,初始HPV - DNA基因型可能是子宫颈细胞学检查结果随后进展的潜在预测标志物。